How does Wegovy affect eating habits and portion sizes?

Wegovy significantly affects eating habits by reducing appetite and naturally decreasing portion sizes. The medication works by mimicking the GLP-1 hormone, which signals fullness to the brain and slows gastric emptying, helping people feel satisfied with smaller amounts of food. Clinical studies show that patients taking Wegovy experience about a 24% reduction in total daily energy intake, with substantial decreases in food consumption at lunch, dinner, and snacks. The medication also reduces food cravings—particularly for high-fat and high-sugar foods—while improving control over eating behaviours. [1][2][3]

Key effects on eating habits and portion sizes:

• Appetite suppression: Wegovy activates brain receptors that control hunger, making people feel less hungry and more satisfied with smaller portions. [2][3][4]
• Slower gastric emptying: Food stays in the stomach longer, creating prolonged feelings of fullness that naturally reduce portion sizes. [5][2]
• Reduced food cravings: Patients report fewer cravings, especially for fatty and sugary foods, and less desire to snack between meals. [3][2]
• Earlier satiety: The medication promotes feeling fuller faster during meals, leading to consuming less food at each sitting. [2][3]
• Better eating control: Clinical trials demonstrate improved control of eating behaviours and reduced impulsive food choices. [1][3]
• Gradual effect development: The full appetite-suppressing effects typically develop over 8–12 weeks as the dose is gradually increased. [2][3]

Sources

• Reduction in energy intake and eating control with semaglutide [1]
• Diabetes UK – Wegovy (semaglutide) overview [2]
• J Clin Endocrinol Metab (2025) – Anti-obesity pharmacotherapy mechanisms & outcomes [3]
• Endocrinology (2025) – Central GLP-1 signalling and appetite regulation [4]
• Review of GLP-1 effects on gastric emptying and satiety [5]